(firstQuint)Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors.

 Besides the main objective, there are 4 other objectives as follows: 1.

 To determine dose-limiting toxicity (DLT) of HM781-36B 2.

 To determine Maximum Tolerated Dose (MTD) of HM781-36B 3.

 To determine the effect of food on the pharmacokinetics after dosed HM781-36B continuously 4.

 To evaluate anticancer activity of HM781-36B in patients with advanced solid malignancies.

 Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors@highlight

The main objective of this study is to determine the maximum tolerated dose (MTD) of HM781-36B continuously.

